Iterum Therapeutics (ITRM) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ITRM is expected to report earnings to fall 10.42% to -21 cents per share on March 31

Iterum Therapeutics ITRM Stock Earnings Reports

Q4'24

Est.

$-0.22

Q3'24

Missed

by $0.06

Q2'24

Beat

by $0.15

Q1'24

Beat

by $0.33

Q4'23

Beat

by $0.11

The last earnings report on November 14 showed earnings per share of -23 cents, missing the estimate of -17 cents. With 668.51K shares outstanding, the current market capitalization sits at 41.27M.

View a ticker or compare two or three

Compare

ITRM

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ITRM
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

an operator, which engages in the healthcare industry focusing on biotechnology business

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

Fitzwilliam Court

Phone

+353 16694820

Employees

Web

https://www.iterumtx.com